Nasdaq17d
UBS Upgrades Confluent (CFLT)
As of February 20, 2025, the average one-year price target for Confluent is $38.52/share. The forecasts range from a low of $30.30 to a high of $44.10. The average price target represents an ...
Nasdaq3d
UBS Upgrades Barrick Gold (GOLD)
Fintel reports that on March 5, 2025, UBS upgraded their outlook for Barrick Gold (NYSE:GOLD) from Neutral to Buy. As of March 4, 2025, the average one-year price target for Barrick Gold is $23.51 ...
Nasdaq5d
UBS Upgrades Arista Networks (ANET)
Fintel reports that on March 5, 2025, UBS upgraded their outlook for Arista Networks (NYSE:ANET) from Neutral to Buy. As of March 4, 2025, the average one-year price target for Arista Networks is ...
Nasdaq18d
UBS Upgrades RTX (RTX)
As of February 19, 2025, the average one-year price target for RTX is $140.20/share. The forecasts range from a low of $87.87 to a high of $166.95. The average price target represents an increase ...
Nasdaq26d
UBS Upgrades Compass (COMP)
As of January 29, 2025, the average one-year price target for Compass is $7.59/share. The forecasts range from a low of $5.56 to a high of $10.50. The average price target represents an increase ...
Nasdaq19d
UBS Upgrades TransDigm Group (TDG)
Fintel reports that on February 24, 2025, UBS upgraded their outlook for TransDigm Group (NYSE:TDG) from Neutral to Buy. As of February 18, 2025, the average one-year price target for TransDigm ...
Nasdaq22d
Fund Update: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Just Disclosed New Holdings
Check out Quiver Quantitative's fund page for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC for more details. This article was originally published on Quiver News ...
Nasdaq22d
Fund Update: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC opened a $58.8M position in $USCA stock
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. Note that there may be inaccuracies in these estimates due to filing errors by the funds ...
UBS Group Upgrades Jazz Pharmaceuticals (NASDAQ:JAZZ) to “Buy”
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) was upgraded by stock analysts at UBS Group from a “neutral” rating to a “buy” rating in a report released on Friday, MarketBeat.com reports. The ...
Nasdaq22d
Fund Update: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC added 149,240 shares of ASTERA LABS ($ALAB) to their portfolio
ASTERA LABS insiders have traded $ALAB stock on the open market 225 times in the past 6 months. Of those trades, 0 have been purchases and 225 have been sales. Here ...
Nasdaq22d
Fund Update: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC opened a $12.0M position in $AZN stock
We have seen $1,253,969 of award payments to $AZN over the last year. Here are some of the awards which we have have seen pay out the most over the last year: Note ...
Nasdaq19d
UBS Upgrades Edison International (EIX)
Fintel reports that on February 18, 2025, UBS upgraded their outlook for Edison International (NYSE:EIX) from Neutral to Buy. As of February 19, 2025, the average one-year price target for Edison ...